As of 2026-04-09, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -10.33 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 15.69 USD, the upside of Olema Pharmaceuticals Inc is -165.81%.
Based on its market price of 15.69 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 165.81%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.33 - -10.33 | -10.33 | -165.81% |
| P/E | (42.83) - (47.75) | (45.54) | -390.2% |
| DDM - Stable | (19.05) - (67.07) | (43.06) | -374.4% |
| DDM - Multi | (16.75) - (47.07) | (24.86) | -258.4% |
| Market Cap (mil) | 1,234.18 |
| Beta | 0.53 |
| Outstanding shares (mil) | 78.66 |
| Enterprise Value (mil) | 1,188.87 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.18% |
| Cost of Debt | 5.00% |
| WACC | 9.17% |